Home

X4 Pharmaceuticals, Inc. - Common Stock (XFOR)

2.9000
-0.0300 (-1.02%)
NASDAQ · Last Trade: Aug 14th, 5:11 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Unusual volume stocks are being observed in Wednesday's session.chartmill.com
These stocks have an unusual volume in today's session
Via Chartmill · August 13, 2025
X4 Pharmaceuticals Stock Rises On Closing Of Upsized Offering, But Brokerage Lowers Price Targetstocktwits.com
The company said that the originally announced offering of $60 million was increased to $85 million to allow for the inclusion of an investor who had a pre-existing investment right.
Via Stocktwits · August 13, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · August 13, 2025
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · August 12, 2025
Earnings Scheduled For May 1, 2025benzinga.com
Via Benzinga · May 1, 2025
Earnings Preview For X4 Pharmaceuticalsbenzinga.com
Via Benzinga · April 30, 2025
Earnings Scheduled For November 13, 2024benzinga.com
Via Benzinga · November 13, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · August 12, 2025
Top movers in Tuesday's sessionchartmill.com
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · August 12, 2025
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · August 12, 2025
Get insights into the top gainers and losers of Tuesday's pre-market session.chartmill.com
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · August 12, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · August 12, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · July 28, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · July 24, 2025
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · July 24, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · July 24, 2025
What's going on in today's sessionchartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session.
Via Chartmill · July 24, 2025
Top 3 Health Care Stocks That May Rocket Higher In Aprilbenzinga.com
Via Benzinga · April 28, 2025
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via Chartmill · April 24, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 24, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · April 17, 2025
Breaking Down X4 Pharmaceuticals: 4 Analysts Share Their Viewsbenzinga.com
Via Benzinga · March 27, 2025
Earnings Scheduled For March 25, 2025benzinga.com
Via Benzinga · March 25, 2025
Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 30, 2025
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And Morebenzinga.com
Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.
Via Benzinga · June 24, 2024